Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com

Skip over primary navigation

EUDRAGIT® | HOMEEUDRAGIT® | HOME
  • About EUDRAGIT®About EUDRAGIT®
  • Products & servicesProducts & services
  • Workshops & eventsWorkshops & events
  • DownloadsDownloads
  • e-Labe-Lab
  • ContactContact

Skip over visual

Skip over functional column



Skip over functional column

EUDRAGIT® - Functional polymers for protective, enteric and sustained-release formulations

Controlled Release
Controlled Release

EUDRAGIT® has the formulations which allow custom-tailored release profiles and releases over a specific period of time.


  • Products & services
  • EUDRAGIT® products
  • Sustained-release formulations

Time-Controlled Drug Release

Whether you need your drug to release over a specific period of time or would like to benefit from the advantages of multi-particulate or matrix formulations - EUDRAGIT® polymers can help you achieve your desired release profile. Drug delivery can be controlled throughout the entire gastrointestinal tract to increase therapeutic effect and patient compliance. Different polymer combinations of EUDRAGIT® RL and RS grades allow custom-tailored release profiles to achieve the desired drug delivery performance. EUDRAGIT® NE an NM grades are neutral ester dispersions which do not require additional plasticizers.

Benefit from EUDRAGIT® coatings with sustained release:

  • Time-controlled release of active ingredients
  • Therapeutically customized release profiles
  • Higher patient compliance due to reduced number of doses to be taken
  • Cost-effective processing

 

Polymer Availability Dissolution Properties
EUDRAGIT® RL 100 Granules Insoluble
High permeability
pH-independent swelling
EUDRAGIT® RL PO Powder
EUDRAGIT® RL 30 D 30% Aqueous
Dispersion
EUDRAGIT® RL 12,5 12,5% Organic
Solution
EUDRAGIT® RS 100 Granules Insoluble
Low permeability
pH-independent swelling
EUDRAGIT® RS PO Powder
EUDRAGIT® RS 30 D 30% Aqueous
Dispersion
EUDRAGIT® RS 12,5 12,5% Organic
Solution
EUDRAGIT® NE 30 D 30% Aqueous
Dispersion
Insoluble, low permeability,
pH-independent swelling
No plasticizer required
Highly flexible
EUDRAGIT® NE 40 D 40% Aqueous
Dispersion
EUDRAGIT® NM 30 D 30% Aqueous
Dispersion

 

 

Overview

Business model
News

Overview

EUDRAGIT® products
  • Enteric formulations
    • EUDRAGIT® L 30 D-55
    • EUDRAGIT® L 100-55
    • EUDRAGIT® L 100
    • EUDRAGIT® L 12,5
    • EUDRAGIT® S 100
    • EUDRAGIT® S 12,5
    • EUDRAGIT® FS 30 D
  • Protective formulations
    • EUDRAGIT® E 100
    • EUDRAGIT® E 12,5
    • EUDRAGIT® E PO
  • Sustained-release formulations
    • EUDRAGIT® RL 100
    • EUDRAGIT® RL PO
    • EUDRAGIT® RL 30 D
    • EUDRAGIT® RL 12,5
    • EUDRAGIT® RS 100
    • EUDRAGIT® RS PO
    • EUDRAGIT® RS 30 D
    • EUDRAGIT® RS 12,5
    • EUDRAGIT® NE 30 D
    • EUDRAGIT® NE 40 D
    • EUDRAGIT® NM 30 D
  • PlasACRYL™ T20
Technical support
  • Laboratories worldwide
    • Laboratories in China
    • Laboratories in Germany
    • Laboratories in India
    • Laboratories in Japan
    • Laboratories in the USA
Formulation development
GMP services
  • GMP facilities in Germany
Proof of concept
Advanced drug delivery

Overview

Workshops
Trade shows
Webinars

Overview

Pharma Polymers News
EUDRAGIT® Quickstarts
Brochures
Scientific posters
Product specifications
Other downloads

Overview

Open the e-Lab
What is the e-Lab?
 
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page